VMD
Viemed Healthcare Inc
9.10$
+0.6%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 24.0% | 24.8% | 24.9% | 27.4% | 28.1% | 29.9% | 27.6% | 30.0% | 24.7% | 22.6% | 25.2% | 26.4% | |
| 6.7% | 8.3% | 4.7% | 5.4% | 6.7% | 9.9% | 5.7% | 10.8% | 5.5% | 6.3% | 4.9% | 5.2% | |
| 6.7% | 8.3% | 4.7% | 5.4% | 6.7% | 9.9% | 5.7% | 10.8% | 5.5% | 6.3% | 4.9% | 5.2% | |
| 12.0% | 11.9% | 15.8% | 16.8% | 16.0% | 14.1% | 15.0% | 14.4% | 14.5% | 11.9% | 15.8% | 15.8% | |
| 3.1% | 3.0% | 2.8% | 2.7% | 2.5% | 2.4% | 2.5% | 2.3% | 2.6% | 2.3% | 2.6% | 2.6% | |
| 19.9% | 19.2% | 19.2% | 20.1% | 19.5% | 18.6% | 18.5% | 17.9% | 28.9% | 27.4% | 29.9% | 28.9% | |
| 0.5% | 0.4% | 0.3% | 0.6% | 0.5% | 0.5% | 0.5% | 0.4% | 0.7% | 0.6% | 0.6% | 0.6% | |
| 27.2% | 26.5% | 24.9% | 26.1% | 25.2% | 24.7% | 23.2% | 23.3% | 33.0% | 33.2% | 26.1% | 28.5% | |
| 21.1% | 20.7% | 19.4% | 19.2% | 21.5% | 21.1% | 19.9% | 20.2% | 21.8% | 19.1% | 20.6% | 23.5% | |
| 1.6% | 1.3% | 1.0% | 1.0% | 1.0% | 0.7% | 0.7% | 0.9% | 1.3% | 1.1% | 1.0% | 1.0% | |
| 6.2% | 4.8% | 1.7% | 6.2% | 6.0% | 5.3% | 7.1% | 6.8% | 7.1% | 5.7% | 6.8% | 5.4% | |
| 5.4% | 3.9% | 3.8% | 5.3% | 2.2% | 2.0% | 2.0% | 1.9% | 9.7% | 5.3% | 4.2% | 3.1% | |
| 72.8% | 73.5% | 75.1% | 72.8% | 73.7% | 74.2% | 75.7% | 75.7% | 66.0% | 65.9% | 72.9% | 70.5% | |
| 50.9% | 51.3% | 51.7% | 49.8% | 50.4% | 50.7% | 51.0% | 50.8% | 48.1% | 47.9% | 53.4% | 53.0% | |
| 27.1% | 26.1% | 26.2% | 24.7% | 24.1% | 23.4% | 23.4% | 22.3% | 20.0% | 18.7% | 20.5% | 20.1% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.